Cargando…
Molecular Correlates of Early Onset of Diabetic Cardiomyopathy: Possible Therapeutic Targets
Diabetes mellitus (DM) is associated with mitochondrial dysfunction and oxidative stress that can lead to diabetic cardiomyopathy (DCM), which can often remain undetected until late stages of the disease. However, myocardial injury occurs before the onset of measurable cardiac dysfunction, although...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9023181/ https://www.ncbi.nlm.nih.gov/pubmed/35464763 http://dx.doi.org/10.1155/2022/9014155 |
_version_ | 1784690280969011200 |
---|---|
author | Wang, Dongjuan Liu, Kun Zhong, Jinyan Li, Xin Zhang, Jie Wang, Gongxin Li, Ni Li, Tianwen Davis, Harvey El-gaby, Ibrahim Hao, Guoliang Ye, Honghua Li, Dan |
author_facet | Wang, Dongjuan Liu, Kun Zhong, Jinyan Li, Xin Zhang, Jie Wang, Gongxin Li, Ni Li, Tianwen Davis, Harvey El-gaby, Ibrahim Hao, Guoliang Ye, Honghua Li, Dan |
author_sort | Wang, Dongjuan |
collection | PubMed |
description | Diabetes mellitus (DM) is associated with mitochondrial dysfunction and oxidative stress that can lead to diabetic cardiomyopathy (DCM), which can often remain undetected until late stages of the disease. However, myocardial injury occurs before the onset of measurable cardiac dysfunction, although its molecular correlates are poorly understood. In this study, we made a DM rat induced by a high-fat diet combined with low and high doses of streptozotocin (STZ) to emulate pre and early DCM. RNA-sequencing analysis of ventricular tissue revealed a differential transcriptome profile and abnormal activation of pathways involved in fatty acid metabolism, oxidative phosphorylation, cardiac structure and function, insulin resistance, calcium signalling, apoptosis, and TNF signalling. Moreover, using high glucose-treated human induced pluripotent stem cell-derived cardiomyocytes (iPSC-CM), we recapitulated the cardiac cellular phenotype of DM and identified several molecular correlates that may promote the development of DCM. In conclusion, we have developed an experimental framework to target pathways underlying the progression of DCM. |
format | Online Article Text |
id | pubmed-9023181 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Hindawi |
record_format | MEDLINE/PubMed |
spelling | pubmed-90231812022-04-22 Molecular Correlates of Early Onset of Diabetic Cardiomyopathy: Possible Therapeutic Targets Wang, Dongjuan Liu, Kun Zhong, Jinyan Li, Xin Zhang, Jie Wang, Gongxin Li, Ni Li, Tianwen Davis, Harvey El-gaby, Ibrahim Hao, Guoliang Ye, Honghua Li, Dan Oxid Med Cell Longev Research Article Diabetes mellitus (DM) is associated with mitochondrial dysfunction and oxidative stress that can lead to diabetic cardiomyopathy (DCM), which can often remain undetected until late stages of the disease. However, myocardial injury occurs before the onset of measurable cardiac dysfunction, although its molecular correlates are poorly understood. In this study, we made a DM rat induced by a high-fat diet combined with low and high doses of streptozotocin (STZ) to emulate pre and early DCM. RNA-sequencing analysis of ventricular tissue revealed a differential transcriptome profile and abnormal activation of pathways involved in fatty acid metabolism, oxidative phosphorylation, cardiac structure and function, insulin resistance, calcium signalling, apoptosis, and TNF signalling. Moreover, using high glucose-treated human induced pluripotent stem cell-derived cardiomyocytes (iPSC-CM), we recapitulated the cardiac cellular phenotype of DM and identified several molecular correlates that may promote the development of DCM. In conclusion, we have developed an experimental framework to target pathways underlying the progression of DCM. Hindawi 2022-04-14 /pmc/articles/PMC9023181/ /pubmed/35464763 http://dx.doi.org/10.1155/2022/9014155 Text en Copyright © 2022 Dongjuan Wang et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Wang, Dongjuan Liu, Kun Zhong, Jinyan Li, Xin Zhang, Jie Wang, Gongxin Li, Ni Li, Tianwen Davis, Harvey El-gaby, Ibrahim Hao, Guoliang Ye, Honghua Li, Dan Molecular Correlates of Early Onset of Diabetic Cardiomyopathy: Possible Therapeutic Targets |
title | Molecular Correlates of Early Onset of Diabetic Cardiomyopathy: Possible Therapeutic Targets |
title_full | Molecular Correlates of Early Onset of Diabetic Cardiomyopathy: Possible Therapeutic Targets |
title_fullStr | Molecular Correlates of Early Onset of Diabetic Cardiomyopathy: Possible Therapeutic Targets |
title_full_unstemmed | Molecular Correlates of Early Onset of Diabetic Cardiomyopathy: Possible Therapeutic Targets |
title_short | Molecular Correlates of Early Onset of Diabetic Cardiomyopathy: Possible Therapeutic Targets |
title_sort | molecular correlates of early onset of diabetic cardiomyopathy: possible therapeutic targets |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9023181/ https://www.ncbi.nlm.nih.gov/pubmed/35464763 http://dx.doi.org/10.1155/2022/9014155 |
work_keys_str_mv | AT wangdongjuan molecularcorrelatesofearlyonsetofdiabeticcardiomyopathypossibletherapeutictargets AT liukun molecularcorrelatesofearlyonsetofdiabeticcardiomyopathypossibletherapeutictargets AT zhongjinyan molecularcorrelatesofearlyonsetofdiabeticcardiomyopathypossibletherapeutictargets AT lixin molecularcorrelatesofearlyonsetofdiabeticcardiomyopathypossibletherapeutictargets AT zhangjie molecularcorrelatesofearlyonsetofdiabeticcardiomyopathypossibletherapeutictargets AT wanggongxin molecularcorrelatesofearlyonsetofdiabeticcardiomyopathypossibletherapeutictargets AT lini molecularcorrelatesofearlyonsetofdiabeticcardiomyopathypossibletherapeutictargets AT litianwen molecularcorrelatesofearlyonsetofdiabeticcardiomyopathypossibletherapeutictargets AT davisharvey molecularcorrelatesofearlyonsetofdiabeticcardiomyopathypossibletherapeutictargets AT elgabyibrahim molecularcorrelatesofearlyonsetofdiabeticcardiomyopathypossibletherapeutictargets AT haoguoliang molecularcorrelatesofearlyonsetofdiabeticcardiomyopathypossibletherapeutictargets AT yehonghua molecularcorrelatesofearlyonsetofdiabeticcardiomyopathypossibletherapeutictargets AT lidan molecularcorrelatesofearlyonsetofdiabeticcardiomyopathypossibletherapeutictargets |